** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Kahr CW9 (left); Kahr K40 (right) ...

MODI'IN, Israel, June 2, 2025 /PRNewswire/ -- KAHR, a clinical-stage biotech company developing DSP107, a first-in-class bi-specific 4-1BB T-cell engager that activates innate and adaptive immunity to ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...

JERUSALEM, June 16, 2021 /PRNewswire/ -- KAHR, a cancer immunotherapy company developing novel multifunctional immuno-recruitment proteins, today announced the first closing of an investment round ...

The Kahr P9 has a 3.9” polygonal rifled barrel with a 1/10 twist, a black polymer frame and a matte stainless slide, which also comes in matte black. It comes standard with 7-round stainless single ...

Kahr Arms, an innovative firearms manufacturer was established in 1981 and has been a leading supplier of computer numerical control (CNC) machine tools and applications engineering. In 1986, the ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Kahr, the maker of functional, ...

KAHR, a maker of cancer immunotherapies, said it has entered into an exclusive licensing agreement with Thomas Jefferson University in Philadelphia to develop and commercialize a number of new cancer ...

The MarketWatch News Department was not involved in the creation of this content. Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with ...